SHEBA VARGHESE: Open Payments
NPI 1386377158 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 28 payments from 10 companies in 2025. Trend: 2023 $1,357 · 2024 $1,386 · 2025 $1,194
Food & beverage: $768Travel & lodging: $426
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 6 | $693 |
| BridgeBio Pharma, Inc. | 6 | $149 |
| Alnylam Pharmaceuticals Inc. | 3 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Veloxis Pharmaceuticals, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: Barostim Neo System, Attruby, AMVUTTRA, JARDIANCE, CAMZYOS, WAINUA, VERQUVO, FUROSCIX.
Industry payments across NY — which companies pay providers there.
